Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow Capsule 22 mm, Gelatin coated capsule with imprint "SUSTIVA;200mg". It contains Efavirenz 200 mg; of Efavirenz[efavirenz];. This belongs to the Human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor pharmacologic class. It is manufactured by Bristol-Myers Squibb Pharma Company. For details please contact your physician.
Basic Information
- Imprint
- SUSTIVA;200mg
- Color
- Yellow
- Shape
- Capsule
- Size
- 22 mm
Drug Information
- Strength
- Efavirenz 200 mg;
- Dosage Form
- Gelatin coated capsule
- RxCUI
- 213390
Pharmaceutical Classification
Related Medications
Other drugs in the same class: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- AtriplaEFAVIRENZ 600 mg;EMTRICITABINE 200 mg;TENOFOVIR DISOPROXIL FUMARATE 300 mg;PINK • OVAL
- COMPLERAemtricitabine 200 mg;rilpivirine hydrochloride 25 mg;tenofovir disoproxil fumarate 300 mg;PURPLE • OVAL
- EDURANTrilpivirine hydrochloride 25 mg;WHITE • ROUND
- Intelenceetravirine 100 mg;WHITE • OVAL
- Intelenceetravirine 200 mg;WHITE • OVAL
- nevirapineNEVIRAPINE 200 mg;WHITE • CAPSULE
- NevirapineNEVIRAPINE 200 mg;WHITE • OVAL
- SUSTIVAefavirenz 50 mg;WHITE;YELLOW • CAPSULE
- SUSTIVAefavirenz 600 mg;YELLOW • OVAL
- ViramuneNEVIRAPINE 200 mg;WHITE • OVAL
Ingredients
- Active Ingredients
- Efavirenz[efavirenz];
- Inactive Ingredients
- Lactose monohydrate;magnesium stearate;sodium lauryl sulfate;sodium starch glycolate type a potato;gelatin, unspecified;titanium dioxide;ferric oxide yellow;silicon dioxide;fd&c blue no. 2;
Additional Information
- Manufacturer
- Bristol-Myers Squibb Pharma Company
- Status (Rx/OTC)
- Not found
- Brand Names
- Sustiva
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.